X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
lenalidomide (726) 726
science & technology (686) 686
life sciences & biomedicine (677) 677
humans (627) 627
multiple myeloma (536) 536
thalidomide - analogs & derivatives (448) 448
multiple myeloma - drug therapy (408) 408
oncology (399) 399
hematology (375) 375
aged (302) 302
male (298) 298
female (285) 285
middle aged (273) 273
bortezomib (272) 272
thalidomide - administration & dosage (256) 256
antineoplastic combined chemotherapy protocols - therapeutic use (252) 252
thalidomide - therapeutic use (223) 223
thalidomide (216) 216
treatment outcome (212) 212
dexamethasone (203) 203
adult (189) 189
dexamethasone - administration & dosage (165) 165
thalidomide - adverse effects (161) 161
antineoplastic agents - therapeutic use (155) 155
care and treatment (135) 135
aged, 80 and over (133) 133
angiogenesis inhibitors (126) 126
medicine & public health (120) 120
antineoplastic combined chemotherapy protocols - adverse effects (116) 116
recurrence (103) 103
multiple myeloma - pathology (97) 97
cancer (95) 95
drug therapy (95) 95
multiple myeloma - mortality (95) 95
pharmacology & pharmacy (92) 92
multiple myeloma - therapy (88) 88
immunologic factors - therapeutic use (79) 79
transplantation (78) 78
disease-free survival (76) 76
patients (76) 76
prognosis (76) 76
analysis (75) 75
chemotherapy (75) 75
retrospective studies (73) 73
stem cells (70) 70
research (69) 69
hematology, oncology and palliative medicine (66) 66
clinical trials (64) 64
clinical trials as topic (64) 64
myeloma (64) 64
multiple myeloma - diagnosis (63) 63
antineoplastic agents - adverse effects (62) 62
dexamethasone - therapeutic use (62) 62
boronic acids - therapeutic use (60) 60
pyrazines - therapeutic use (60) 60
stem cell transplantation (60) 60
relapse (58) 58
thalidomide - pharmacology (56) 56
boronic acids - administration & dosage (54) 54
pyrazines - administration & dosage (53) 53
animals (52) 52
antineoplastic agents - administration & dosage (51) 51
antineoplastic combined chemotherapy protocols - administration & dosage (51) 51
drug therapy, combination (51) 51
multiple myeloma - complications (50) 50
survival rate (50) 50
transplantation, autologous (50) 50
lenalidomide - administration & dosage (49) 49
survival analysis (48) 48
dexamethasone - adverse effects (47) 47
dose-response relationship, drug (46) 46
risk factors (46) 46
diseases (45) 45
health aspects (45) 45
survival (45) 45
angiogenesis inhibitors - therapeutic use (44) 44
multiple myeloma - genetics (44) 44
hematopoietic stem cell transplantation (43) 43
follow-up studies (42) 42
disease progression (41) 41
dosage and administration (41) 41
pomalidomide (41) 41
lymphomas (39) 39
melphalan (39) 39
combined modality therapy (38) 38
drug administration schedule (38) 38
drug resistance, neoplasm (38) 38
medical research (38) 38
antineoplastic agents - pharmacology (37) 37
immunomodulation (37) 37
steroids (37) 37
remission induction (36) 36
lenalidomide - therapeutic use (35) 35
neoplasm recurrence, local - drug therapy (35) 35
hemic and lymphatic diseases (34) 34
immunologic factors - adverse effects (34) 34
internal medicine (34) 34
toxicity (33) 33
cancer research (32) 32
development and progression (32) 32
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (807) 807
German (7) 7
French (3) 3
Japanese (3) 3
Russian (3) 3
Italian (2) 2
Chinese (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
The New England journal of medicine, ISSN 1533-4406, 04/2017, Volume 376, Issue 14, pp. 1311 - 1320
Journal Article
Lancet Oncology, The, ISSN 1470-2045, 2016, Volume 17, Issue 11, pp. 1569 - 1578
Journal Article
The Lancet (British edition), ISSN 0140-6736, 02/2017, Volume 389, Issue 10068, pp. 519 - 527
Journal Article
Blood, ISSN 0006-4971, 09/2011, Volume 118, Issue 11, pp. 2970 - 2975
Journal Article
Journal Article
Journal Article
British journal of haematology, ISSN 1365-2141, 07/2009, Volume 146, Issue 2, pp. 164 - 170
Journal Article